These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14509555)

  • 1. Tolerance to bronchodilating effects of salmeterol in COPD.
    Donohue JF; Menjoge S; Kesten S
    Respir Med; 2003 Sep; 97(9):1014-20. PubMed ID: 14509555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol.
    Donohue JF; van Noord JA; Bateman ED; Langley SJ; Lee A; Witek TJ; Kesten S; Towse L
    Chest; 2002 Jul; 122(1):47-55. PubMed ID: 12114338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study.
    Bateman ED; van Dyk M; Sagriotis A
    Pulm Pharmacol Ther; 2008; 21(1):20-5. PubMed ID: 17118684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD.
    Briggs DD; Covelli H; Lapidus R; Bhattycharya S; Kesten S; Cassino C
    Pulm Pharmacol Ther; 2005; 18(6):397-404. PubMed ID: 16179215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional impact of adding salmeterol and tiotropium in patients with stable COPD.
    Cazzola M; Centanni S; Santus P; Verga M; Mondoni M; di Marco F; Matera MG
    Respir Med; 2004 Dec; 98(12):1214-21. PubMed ID: 15588043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bronchodilator efficacy of combined salmeterol and tiotropium in patients with chronic obstructive pulmonary disease].
    Baloira Villar A; Vilariño Pombo C
    Arch Bronconeumol; 2005 Mar; 41(3):130-4. PubMed ID: 15766465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD patients.
    Beier J; van Noord J; Deans A; Brooks J; Maden C; Baggen S; Mehta R; Cahn A
    Int J Chron Obstruct Pulmon Dis; 2012; 7():153-64. PubMed ID: 22419863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.
    Aaron SD; Vandemheen KL; Fergusson D; Maltais F; Bourbeau J; Goldstein R; Balter M; O'Donnell D; McIvor A; Sharma S; Bishop G; Anthony J; Cowie R; Field S; Hirsch A; Hernandez P; Rivington R; Road J; Hoffstein V; Hodder R; Marciniuk D; McCormack D; Fox G; Cox G; Prins HB; Ford G; Bleskie D; Doucette S; Mayers I; Chapman K; Zamel N; FitzGerald M;
    Ann Intern Med; 2007 Apr; 146(8):545-55. PubMed ID: 17310045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.
    Brusasco V; Hodder R; Miravitlles M; Korducki L; Towse L; Kesten S
    Thorax; 2003 May; 58(5):399-404. PubMed ID: 12728159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids.
    Hodder R; Kesten S; Menjoge S; Viel K
    Int J Chron Obstruct Pulmon Dis; 2007; 2(2):157-67. PubMed ID: 18044688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of response to tiotropium versus salmeterol in asthmatic adults.
    Peters SP; Bleecker ER; Kunselman SJ; Icitovic N; Moore WC; Pascual R; Ameredes BT; Boushey HA; Calhoun WJ; Castro M; Cherniack RM; Craig T; Denlinger LC; Engle LL; Dimango EA; Israel E; Kraft M; Lazarus SC; Lemanske RF; Lugogo N; Martin RJ; Meyers DA; Ramsdell J; Sorkness CA; Sutherland ER; Wasserman SI; Walter MJ; Wechsler ME; Chinchilli VM; Szefler SJ;
    J Allergy Clin Immunol; 2013 Nov; 132(5):1068-1074.e1. PubMed ID: 24084072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
    Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.
    Cazzola M; Di Perna F; Noschese P; Vinciguerra A; Calderaro F; Girbino G; Matera MG
    Eur Respir J; 1998 Jun; 11(6):1337-41. PubMed ID: 9657576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
    Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
    Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchodilation improves endurance but not muscular efficiency in chronic obstructive pulmonary disease.
    van der Vaart H; Postma DS; Grevink R; Roemer W; ten Hacken N
    Int J Chron Obstruct Pulmon Dis; 2011; 6():229-35. PubMed ID: 21660300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An acute bronchodilator test with tiotropium or salmeterol does not allow a subdivision of patients according to responses.
    Matera MG; Sanduzzi A; Ponticiello A; Vatrella A; Salzillo A; Cazzola M
    Respiration; 2005; 72(5):466-70. PubMed ID: 16210884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease.
    Cazzola M; Matera MG; Di Perna F; Calderaro F; Califano C; Vinciguerra A
    Respir Med; 1998 Feb; 92(2):354-7. PubMed ID: 9616538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group.
    Casaburi R; Briggs DD; Donohue JF; Serby CW; Menjoge SS; Witek TJ
    Chest; 2000 Nov; 118(5):1294-302. PubMed ID: 11083677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.